首页> 外文期刊>Sleep >Cognitive behavioral treatments for insomnia and pain in adults with comorbid chronic insomnia and fibromyalgia: clinical outcomes from the SPIN randomized controlled trial
【24h】

Cognitive behavioral treatments for insomnia and pain in adults with comorbid chronic insomnia and fibromyalgia: clinical outcomes from the SPIN randomized controlled trial

机译:具有同型慢性失眠和纤维瘤的成人失眠和疼痛的认知行为治疗:旋转随机对照试验中的临床结果

获取原文
获取原文并翻译 | 示例
       

摘要

Study Objectives To examine the effects of cognitive behavioral treatments for insomnia (CBT-I) and pain (CBT-P) in patients with comorbid fibromyalgia and insomnia. Methods One hundred thirteen patients (Mage = 53, SD = 10.9) were randomized to eight sessions of CBT-I (n = 39), CBT-P (n = 37), or a waitlist control (WLC, n = 37). Primary (self-reported sleep onset latency [SOL], wake after sleep onset [WASO], sleep efficiency [SE], sleep quality [SQ], and pain ratings) and secondary outcomes (dysfunctional beliefs and attitudes about sleep [DBAS]; actigraphy and polysomnography SOL, WASO, and SE; McGill Pain Questionnaire; Pain Disability Index; depression; and anxiety) were examined at posttreatment and 6 months. Results Mixed effects analyses revealed that both treatments improved self-reported WASO, SE, and SQ relative to control at posttreatment and follow-up, with generally larger effect sizes for CBT-I. DBAS improved in CBT-I only. Pain and mood improvements did not differ by group. Clinical significance analyses revealed the proportion of participants no longer reporting difficulties initiating and maintaining sleep was higher for CBT-I posttreatment and for both treatments at 6 months relative to control. Few participants achieved >50% pain reductions. Proportion achieving pain reductions of >30% (~1/3) was higher for both treatments posttreatment and for CBT-I at 6 months relative to control. Conclusions CBT-I and CBT-P improved self-reported insomnia symptoms. CBT-I prompted improvements of larger magnitude that were maintained. Neither treatment improved pain or mood. However, both prompted clinically meaningful, immediate pain reductions in one third of patients. Improvements persisted for CBT-I, suggesting that CBT-I may provide better long-term pain reduction than CBT-P. Research identifying which patients benefit and mechanisms driving intervention effects is needed.
机译:研究目的,研究认知行为治疗对合并纤维肌痛和失眠患者的失眠(CBT-1)和疼痛(CBT-P)的影响。方法将一百13名患者(MAGE = 53,SD = 10.9)随机化为CBT-I(n = 39),CBT-P(n = 37)或待客控制(WLC,N = 37)的八个会话。初级(自我报告的睡眠起始延迟[SOL],睡眠后唤醒[WASO],睡眠效率[SE],睡眠质量[SEQ]和疼痛评级)和次要结果(关于睡眠的功能失调信念和态度[DBA]; Atightaphy和PolysomNography Sol,WASO和SE;麦吉尔疼痛问卷;疼痛残疾指数;抑郁症;和焦虑)在后处理和6个月内检查。结果混合效应分析显示,两种治疗方法都改善了自我报告的WASO,SE和SQ相对于对后续和随访的控制,具有较大的CBT-I效果尺寸。 DBA仅在CBT-I中提升。疼痛和情绪改善的痛苦没有差异。临床意义分析揭示了参与者的比例不再报告困难的困难,即CBT-I治疗和6个月的治疗相对于对照,睡眠更高。少数参与者达到了> 50%的止痛药。在6个月相对于对照中,治疗治疗治疗和CBT-1的治疗均比止血剂> 30%(〜1/3)的比例较高。结论CBT-I和CBT-P改善了自我报告的失眠症症状。 CBT-I促进改进维护的较大幅度。任何治疗都没有改善疼痛或情绪。然而,两者都促使临床有意义的临床意义,三分之一患者的立即止痛药。对于CBT-I持续的改进,表明CBT-I可以提供比CBT-P更好的长期疼痛减少。鉴定需要研究哪些患者的受益和机制驾驶干预效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号